About hemophilia B Hemophilia B, also called the Christmas disease, is a blood coagulation disorder
due to the deficiency or improper function of factor IX.
The first patent relates to a method for diagnosing a human blood coagulation disorder
called resistance to APC (also known as activated protein C resistance), while the second patent additionally relates to a method for determining the presence of gene mutations of Factor V, which is one of the causes of thrombophilia.
Baldwin died from a blood coagulation disorder
unrelated to radiation or any other exposure.
Factor V Leiden is the most common hereditary blood coagulation disorder
in the United States, present in 5% of the white Caucasian population and present in 1.
Hemophilia A is a blood coagulation disorder
caused by a genetic deficiency in the body's ability to produce Factor VIII.
Bayer Corporation, a market leader in the treatment of this hereditary blood coagulation disorder
, is the U.
Hemophilia is a genetic blood coagulation disorder
affecting one in 25,000, primarily males, worldwide.
This ontract would include Edelman having responsibility for the strategic planning and execution of trade activities in the field of blood coagulation disorders
Established in 2002, the company manufactures and supplies biological re-agents for the monitoring of blood coagulation disorders
, oral anticoagulants and anti-platelet drugs in laboratories and hospitals.
The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders
, and autoimmune diseases.
com/research/a4f4b9/haemophilia_and_bl) has announced the addition of the "Haemophilia and Blood Coagulation Disorders
Therapy Area Pipeline Report" report to their offering.
Last year's star exporter was Hartlepool's Hart Biologicals, which manufactures and supplies biological reagents for the monitoring of blood coagulation disorders
, oral anticoagulants and anti-platelet drugs in doctors' surgeries, laboratories and hospitals.